Pune, India, March 12, 2021 (GLOBE NEWSWIRE) -- The global rheumatoid arthritis testing market will derive growth from the high prevalence of the disease across the world. According to a report by Fortune Business Insights, titled “Rheumatoid Arthritis Testing Market Size, Share & Industry Analysis, By Test Type (Serological Tests, Rheumatoid Arthritis Severity Tests & Medication Monitoring Tests, Imaging Tests), By End User (Hospitals & Clinics, Diagnostic Centers, Others) and Regional Forecast, 2019-2026,” the market will benefit from recent technological advancements in testing equipment associated with diagnosis of the disease.
Rheumatoid arthritis is a long term severe disorder that directly affects the immune system of the human body. It is a serious disorder that comes with side effects such as swelling and inflammation around the affected area.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/rheumatoid-arthritis-testing-market-101523
Moreover, excessive pain is caused within body joints and organs of the body. The disease can affect several joints in the body, which in turn has led to a severe emphasis on the research and development of treatment options associated with the disease. As joints are directly responsible for body movements and labor, there is a huge need for efficient treatment methods.
According to the Rheumatoid Arthritis Support Network, around 1.3 million people in the United States are affected by the disease, which accounts for nearly 1% of the global population. Such a high prevalence of the disease will open up a huge potential for growth for the companies operating in the market. The report analyzes ongoing market trends and discusses the current scenario, with primary focus on aspects such as competitive landscape, growth drivers, and major product launches in recent years.
Driven by High Prevalence of Rheumatoid Arthritis, North America to Emerge as the Leading Region
The report segments the market based on regional demographics into North America, Latin America, Europe, Middle East and Africa, and Asia Pacific. Among these regions, North America will emerge as the leading region in the coming years, mainly attributable to the growing prevalence of rheumatoid arthritis in this region.
According to the Centers for Disease Control and Prevention, by 2040, around 78.4 million people across the world will be diagnosed with the disease. Furthermore, an estimated 34.6 million people will report activity limitations due to rheumatoid arthritis. This will contribute to the growth of the market in North America.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/rheumatoid-arthritis-testing-market-101523
Advances in Treatment Methods to Favor Market Growth
The growing penetration of technology in the healthcare industry has given rise to exceptional treatment methods. Technology has bettered the treatment and diagnosis methods associated with rheumatoid arthritis. As a result, the demand for rheutmatoid arthritis test equipment has increased drastically in recent years.
Technological advancements have yielded benefits such as improved patient outcomes, accurate diagnosis and testing procedures, ease of use, and reduce cost for testing. In 2019, Microdrop LLC announced the launch of a new arthritis screening method, wherein patients would be able to avail testing methods from the comfort of their homes.
This eliminates the need for hospital visits and huge favors patients who are either bedridden or have physical disabilities. Microdrop’s latest product will help the company generate a substantial amount of rheumatoid arthritis testing market revenue in the coming years. This, in turn, will influence the growth of the market in a positive way.
Quick Buy - Rheumatoid Arthritis Testing Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/101523
List of the Companies Profiled in the Global Market:
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- Beckman Coulter, Inc.
- Siemens Healthcare GmbH
- Microdrop LLC (imaware)
- Augurex Life Sciences Corp.
- Qiagen
- Svar Life Science AB (Euro Diagnostica)
- Exagen Inc.
- Aviva Systems Biology Corporation
- Bio-Rad Laboratories Inc.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/rheumatoid-arthritis-testing-market-101523
Segmentation:
By Test Type
- Serological Tests
- Erythrocyte Sedimentation Rate (ESR)
- Anti-Cyclic Citrullinated Peptide (anti-CCP)
- Rheumatoid Factor (RF)
- C-reactive Protein (CRP)
- Anti-nuclear antibody (ANA)
- Uric Acid
- Others
- Rheumatoid Arthritis Severity Tests & Medication Monitoring Tests
- Salicylate Level Test
- Muscle Enzyme Test
- Creatinine Test
- Multibiomarker Disease Activity (MBDA)
- Imaging Tests
- MRI
- X-Ray
- Ultrasound
By End User
- Hospitals & Clinics
- Diagnostic Centers
- Others
By Geography
- North America (USA and Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
- Latin America (Brazil, Mexico and Rest of Latin America)
- Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/rheumatoid-arthritis-testing-market-101523
Have a Look at Related Reports:
Wound Care Market Size, Share & Covid-19 Impact Analysis, By Type (Advanced Wound Dressing, Traditional Wound Care Products, Negative Pressure Wound Therapy, Bioactives, and Others), By Application (Chronic Wounds, and Acute Wounds), By End User (Hospitals, Clinics, Homecare Settings, and Others), and Regional Forecast, 2020-2027
Veterinary Drugs Market Size, Share and Industry Analysis by Product (Anti-infectives, Anti-inflammatory, Parasiticides, Others), By Animal (Companion, Livestock), By Route of Administration (Oral, Parenteral,Topical), Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, Others,) and Regional Forecast, 2018 - 2025
Active Wound Care Market Size, Share and Industry Analysis by Product Type (Biological Skin Equivalents, Growth Factors, Biological Dressings, Others), By Indication (Diabetic Foot Ulcers, Pressure Ulcers, Lower Limb Ulcers), By End User (Hospitals, Clinics, Home Care Settings), and Regional Forecast 2018-2025
Idiopathic Inflammatory Myopathy Treatment Market Size, Share & Industry Analysis, By Disease Type (Dermatomyositis, Polymyositis, Necrotizing Autoimmune Myopathy, Others), By Treatment (Corticosteroids, Immunosuppressants, Others), By Route of Administration (Oral, Intravenous, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs